NEW YORK–(BUSINESS WIRE)– December 08, 2020 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted
Continue reading »
Home »
NEW YORK–(BUSINESS WIRE)– December 08, 2020 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted
Continue reading »PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label
Continue reading »TARRYTOWN, N.Y., Oct. 28, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive, prospective results from an ongoing Phase 2/3 seamless trial
Continue reading »October 26, 2020 — The ACTIV-3 clinical trial evaluating the investigational monoclonal antibody LY-CoV555 in hospitalized patients with COVID-19 will
Continue reading »BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris
Continue reading »23 October 2020 — Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators
Continue reading »FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD)
Continue reading »CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 13, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create
Continue reading »Anapolon (Anapolon Ultra, Androlik, Anapolan, Dynasten, Androver, Sinasteron, Oxiged) – the active substance Oxymetholone, is an anabolic drug that promotes
Continue reading »New research led by The University of Western Australia will lead to a world-first in testing strategy for penicillin allergy
Continue reading »